Hologic Selenia

Register to receive a free US Market for Female and Neonatal Diagnostic Devices – 2016 report synopsis and brochure

According to a new series of reports on the female and neonatal diagnostic device market by iData Research (www.idataresearch.com), new mammography technologies and the growth of complementary modalities have significantly grown the U.S. breast imaging market. The breast imaging market includes analog, computed and digital mammography, digital breast tomosynthesis, manual and automated breast ultrasound, gamma imaging, positron emission mammography and breast MRI coils.

By 2022, the mammography market is estimated to reach $607.6 million in the United States. The disappearance of analog by the takeover of digital radiography (DR) mammography has resulted in less incentive to switch to computed radiography (CR). With the mammography market becoming a replacement market, the only segment remaining to drive market growth is the new digital breast tomosynthesis (DBT) market.

“The installed base and average selling price of mammography imaging systems will increase driven by the unit sales of DBT,” explains Dr. Kamran Zamanian, CEO of iData. “By 2022, no analog mammography systems are expected to be sold, as they will be their digital counterparts.”

2D digital mammography comprises over 60% of the mammography unit installed base. Aside from mammography, one major trend in breast imaging is the increasing number of recommendations regarding the use of ultrasound and MRI for women with dense breast tissue. These alternate modalities offer the improved screening capabilities for women with dense breast tissue without the use of ionizing radiation. However, these modalities are currently seen as complementary technologies to standard mammography.

Hologic is the leading competitor in the U.S. market for breast imaging led by their market share in the DR and DBT mammography markets with its Selenia™ DR and DBT systems. Being the first company to receive FDA approval for DBT systems by almost four years has provided Hologic a substantial advantage in the DBT market. The company has also developed SecurView DX™ workstation to be used with digital mammography stations to enhance workflow. Hologic has been seeing lower ASPs for its mammography units in the United States, but this has been offset by increases in digital mammography unit sales outside the United States.

GE Healthcare is the second leading competitor in the U.S. breast imaging market. The company has been producing mammography systems for over 50 years. Its DBT system, the SenoClaire™, received FDA approval in August 2014 becoming the second DBT system to receive FDA approval. GE Healthcare has used its strong hospital network to quickly begin selling the SenoClaire™ brand systems. Additional competitors in the breast imaging market include Philips Medical Systems, Siemens Healthcare, Fujifilm, Toshiba, SuperSonic Imagine, SonoCiné, CMR-Naviscan, Hitachi, Gamma Medica Inc., Dilon Technologies, Machnet B.V. and Planmed OY among others.

For Further Information
More on the breast imaging market in the US can be found in a report series published by iData Research entitled the US Market for Female and Neonatal Diagnostic Devices. The reports cover: bone densitometry, DXA markets, breast biopsy devices, core needle devices, vacuum-assisted breast biopsy devices, breast imaging equipment, mammography, obstetrics and gynecology ultrasound equipment, fetal and neonatal monitoring devices, infant warmer and incubators, NICU, and gynecological chairs.

Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about breast imaging market data or procedure data, register online or email us at [email protected] for a US Market for Female and Neonatal Diagnostic Devices report series brochure and synopsis.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by State, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.

Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook: facebook.com/iDataResearch
Follow us on LinkedIn: linkedin.com/company/idata-research
Follow us on Twitter: twitter.com/iDataResearch